Home 5 Lab Industry Advisor 5 Laboratory Industry Report 5 Deals-lir 5 Dx Deals: Outreach Deals by Quest, Labcorp Are Still Ramping Up

Dx Deals: Outreach Deals by Quest, Labcorp Are Still Ramping Up

by | Jul 24, 2024 | Deals-lir, Essential, Lab Industry Advisor

Though the two national players have closed dozens of such deals over the past decade, much runway for new transactions apparently remains

A decade into the practice of national laboratories acquiring the outreach businesses of hospitals and hospital systems, there appears to be no signs of such transactions easing up, with the trend accelerating in 2024.

Just over halfway through this year, Quest Diagnostics has already announced or closed acquisition of three outreach businesses. Labcorp has made two outreach acquisitions and entered into a relationship with Naples Comprehensive Healthcare that looks very much like an outreach-style deal.1 The two lab testing giants have closed at least 29 outreach acquisitions or similarly structured deals since 2013, records show (see “Outreach Deals Involving Quest Diagnostics” and “Outreach Deals Involving Labcorp” tables below).

Laboratory outreach has been a longstanding business for large and medium-sized hospitals and healthcare systems. Such a business means hospitals are performing testing for regional providers such as physician practices, clinics, long-term care facilities, and other similar entities.

Although an outreach business can bring in tens of millions of dollars a year in revenue for hospitals, the logistics of running a laboratory and courier service big enough to accommodate these clients can be overwhelming. Many hospitals have found that simply reaping a big windfall and shedding numerous headaches by selling their outreach business makes more sense.

Quest announced two deals in as many weeks in late June and early July. It came to terms on June 26 to essentially operate the outreach business of Allina Health, which operates 12 hospitals in Minnesota and western Wisconsin.2 On July 10, it announced a deal to acquire the outreach business of OhioHealth, which operates 15 hospitals, clinics, and other services in 47 of Ohio’s 88 counties.3

“Allina Health selected Quest Diagnostics for its specialized expertise, leadership in laboratory services, and commitment to quality, collaboration, and patient care,” said Quest spokesperson Jennifer Petrella.

For Labcorp, in April, the company announced the closing of a deal to acquire the outreach business in Northern California and Orange County, CA, of Providence, a Washington state-based system that operates 51 hospitals in five western states.4 Also in April, Labcorp closed a deal to acquire the outreach business of Baystate Health, which operates five hospitals in Massachusetts.5

A bar graph in two shades of blue showing the number of lab outreach deals closed by Quest Diagnostics and Labcorp from 2020 to 2024.
Figure 1: The number of lab outreach deals announced or closed by Quest Diagnostics and Labcorp from 2020 to 2024. Note that Labcorp did not announce or close any outreach deals in 2021. Source: Based on information from Quest and Labcorp press release archives accessed July 2024. See “Outreach Deals Involving Quest Diagnostics” and “Outreach Deals Involving Labcorp” tables below for more details.

Terms of outreach deals are rarely, if ever, disclosed. But some outreach businesses are of a significant size. Northwestern Medicine Central DuPage Hospital and NewYork-Presbyterian / Weill Cornell Medical Center reported revenue from Medicare Part B and Clinical Laboratory Fee Schedule (CLFS) payments of $15.5 million and $14.3 million, respectively, in 2019, according to the trade publication Laboratory Economics. The top 25 outreach programs generated combined Part B and CLFS revenue of more than $168 million in 2019.6

According to Bruce Carlson, publisher of the Eye on IVD Newsletter, acquiring outreach businesses serves numerous purposes for Quest and Labcorp. Not only are they profitable, but such deals eliminate regional competitors for bread-and-butter lab business. And there is still a lot of runway to make deals. Carlson cited data indicating there is still $250 million of outreach lab business in the Boston area alone that remains in the hands of hospital operators. And that’s even with Quest and Labcorp controlling $400 million of that market through outreach acquisitions from Baystate, Tufts Health, and Steward Health Care System.

Regarding the Allina deal, Quest’s focus will be on the system’s ambulatory clinic sites and not inpatient operations, according to Allina spokesperson Jennifer Steingas. Quest will provide testing services through its laboratory in Wood Dale, IL, she added.

Petrella said that many of the employees on Allina’s outreach operation were offered jobs with Quest.

The OhioHealth deal is of a similar structure, with most outreach testing being moved to Quest’s lab in the Pittsburgh, PA, area, the company said in a statement.3

References:

    1. https://www.labcorp.com/labcorp-and-naples-comprehensive-healthcare-announce-strategic-agreement-lab-operations

    1. https://newsroom.questdiagnostics.com/2024-06-26-Quest-Diagnostics-to-Acquire-Select-Lab-Assets-from-Allina-Health

    1. https://newsroom.questdiagnostics.com/2024-07-10-Quest-Diagnostics-to-Acquire-Outreach-Laboratory-Services-of-OhioHealth

    1. https://www.labcorp.com/labcorp-finalizes-acquisition-providences-outreach-laboratory-business-northern-california-and

    1. https://www.labcorp.com/labcorp-and-baystate-health-finalize-strategic-relationship-diagnostics-services-0

  1. https://www.laboratoryeconomics.com/top-25-hospital-outreach-labs-for-2019/

Outreach Deals Involving Quest Diagnostics

Outreach Business Acquired Date Transaction Announced or Closed
OhioHealth July 2024
Allina Health June 2024
Steward Health Care System January 2024
Northern Light Laboratory March 2023
Summa Health November 2022
Mercy June 2021
Ascension St. Vincent and Community Health Network June 2020
Memorial Hermann Health System January 2020
Marin General Hospital October 2018
Hurley Medical Center October 2018
Hartford HealthCare (two hospitals only) September 2017
Cape Cod Healthcare June 2017
PeaceHealth May 2017
Clinical Laboratory Partners February 2016
MemorialCare Health System August 2015
Charlotte Hungerford Hospital (structured as a management contract) April 2014
Dignity Health (CommonSpirit Health) June 2013
UMass Memorial Medical Center January 2013
Source: Quest Diagnostics press release archives, accessed July 2024

Outreach Deals Involving Labcorp

Outreach Business Acquired Date Transaction Announced or Closed
Providence (limited to parts of California) April 2024
Baystate Health April 2024
Legacy Health November 2023
Tufts Medicine August 2023
Jefferson Health July 2023
Ascension October 2022
RWJBarnabas Health August 2022
AtlantiCare May 2022
Prisma Health March 2022
Franciscan Missionaries of Our Lady Health System September 2020
Mount Sinai Health System May 2017
Source: Labcorp press release archives, accessed July 2024

********

The following mergers, acquisitions, and joint ventures were announced by laboratories between late June and mid-July:

Mergers and Acquisitions

Partner 1 Partner 2 Date Announced Deal Summary
Quest Diagnostics OhioHealth July 10, 2024 Objective: To streamline OhioHealth’s laboratory operations.

Dynamic: Quest is acquiring OhioHealth’s outreach laboratory business for an undisclosed sum.

Quest Diagnostics OMERS July 3, 2024 Objective: To expand Quest’s footprint in North America.

Dynamic: Quest is acquiring OMERS subsidiary LifeLabs for $985 million. LifeLabs operates medical labs throughout Canada.

Quest Diagnostics Allina Health June 26, 2024 Objective: To streamline Allina Health’s laboratory operations.

Dynamic: Quest is acquiring Allina Health’s outreach laboratory business for an undisclosed sum.

Source: Company press releases

Strategic Alliances

Partner 1 Partner 2 Date Announced Deal Summary
Labcorp Naples Comprehensive Healthcare July 11, 2024 Objective: To improve Naples’ laboratory services.

Dynamic: Labcorp will manage both Naples’ inpatient lab operations. Its oversight will expand to the hospital system’s physician network later this year.

Surfix Diagnostics Netherlands Cancer Institute July 10, 2024 Objective: To improve screening methods for colorectal cancer.

Dynamic: Dutch researchers will use Surfix’s photonic diagnostics platform to improve techniques for earlier detection of colorectal cancer.

C2N Diagnostics Mayo Clinic Laboratories June 27, 2024 Objective: To increase the availability of C2N’s tests for mild cognitive impairment in older individuals.

Dynamic: Mayo Clinic will offer the test as an optional service to patients.

Source: Company press releases

Government Contracts/Grants

Grantor Grantee Date Announced Summary
National Institutes of Health Metabolon June 25, 2024 The NIH has awarded $300,000 to Metabolon to create advanced monitoring and predictive lab tools to monitor the progress of type 1 diabetes.
National Institutes of Health University of Florida June 24, 2024 The NIH has awarded $2.8 million to the University of Florida to develop an at-home test kit for HIV.
Source: Company/university press releases, NIH Funding database

Subscribe to view Essential

Start a Free Trial for immediate access to this article